Sanofi to purchase Kymab and add OX40L monoclonal antibody to its pipeline
Sanofi is set to acquire Cambridge, UK-headquartered Kymab and thereby add KY1005 to its pipeline, a human monoclonal antibody targeting
Read moreSanofi is set to acquire Cambridge, UK-headquartered Kymab and thereby add KY1005 to its pipeline, a human monoclonal antibody targeting
Read moreThe EC and UK have granted authorisation for the use of the Moderna COVID-19 Vaccine in individuals 18 years of
Read moreDrug regulators in the United Kingdom have approved a second COVID-19 vaccine for emergency use today, for the active immunisation
Read moreEuropean Union nations, including France, Germany, Italy, Austria, the Czech Republic, Bulgaria, Greece, Latvia, Portugal and Spain have commenced mass
Read moreThe United Kingdom could approve AstraZeneca’s COVID-19 vaccine as early as next week as the British-swedish pharmaceutical company seems to
Read moreThe U.S. FDA has approved Moderna’s COVID-19 vaccine for emergency use. Moderna’s vaccine becomes the second to be approved by
Read moreDutch data logger manufacturer, SenseAnywhere, offers a simple solution to overcome the COVID-19 vaccine supply chain challenge. The company has
Read moreEli Lilly & Co and Prevail Therapeutics announced a definitive agreement for Lilly to acquire Prevail for a total consideration
Read moreThe United States FDA has approved the emergency use of Pfizer and BioNTech’s COVID-19 vaccine on Friday, paving the way
Read moreRoche revealed a new collaboration agreement with Moderna to use the Elecsys® Anti-SARS-CoV-2 S antibody assay in Moderna’s COVID-19 vaccine
Read more